Vietnam Healthcare Market Research Report: Size, Share, Trends & Forecast (2026-2032)

By Healthcare Expenditure Type (Public Healthcare Expenditure, Private Healthcare Expenditure, Out-of-Pocket Expenditure), By Pharmaceutical Segment (Prescription Drugs, Over-the-Counter (OTC) Drugs,... ... ounter (OTC) Drugs, Generic Drugs, Branded Drugs, Biologics & Biosimilars), By Therapeutic Area (Cardiovascular Diseases, Oncology, Diabetes, Respiratory Diseases, Neurology, Infectious Diseases, Others), By Medical Device Type (Diagnostic Imaging Devices, Patient Monitoring Devices, Surgical Equipment, In-vitro Diagnostics, Orthopedic Devices, Cardiovascular Devices, Others), By Technology Type (Artificial Intelligence in Healthcare, Telemedicine & Remote Monitoring, Electronic Health Records (EHR), Healthcare Analytics, Robotic Surgery, Wearables & Health Apps), By Healthcare Workforce (Physicians, Nurses, Dentists, Allied Health Professionals), By Insurance Type (Public Health Insurance, Private Health Insurance), By Disease Category (Chronic Diseases, Infectious Diseases, Mental Health Disorders), By End User (Hospitals, Clinics, Diagnostic Centers / Laboratories, Ambulatory Surgical Centers, Home Healthcare, Research Institutes, Pharmacies, Others) Read more

  • Healthcare
  • Mar 2026
  • 160
  • PDF, Excel, PPT

Vietnam Healthcare Market Report Key Takeaways:

  • The Vietnam Healthcare Market size was valued at USD 11.85 million in 2025 and is projected to grow from USD 13.95 million in 2026 to USD 22.93 million by 2032, exhibiting a CAGR of 8.64% during 2026-32.
  • About 25% of patients in Vietnam’s healthcare system in 2026 were affected by cardiovascular diseases, highlighting a significant prevalence.
  • Cancer was another common condition, impacting approximately 35% of the patient population in Vietnam’s healthcare system in 2026.
  • Vietnam’s healthcare infrastructure includes 1,718 hospitals, over 350,000 beds, and numerous rehabilitation and residential care facilities.

Market Insights & Analysis: Vietnam Healthcare Market Landscape (2026-32):

The Vietnam Healthcare Market size was valued at USD 11.85 million in 2025 and is projected to grow from USD 13.95 million in 2026 to USD 22.93 million by 2032, exhibiting a CAGR of 8.64% during the forecast period, i.e., 2026-32.

Vietnam’s healthcare landscape is transitioning through structural reforms and investment in service quality, underpinned by ongoing national health agendas focused on disease prevention, primary care strengthening, and digital transformation. Politburo Resolution No. 72 (2025) and the recently adopted Law on Disease Prevention have reoriented the system toward proactive health promotion and expanded preventive services beyond traditional infectious disease control. According to 2025 data, non-communicable diseases (NCDs), including cardiovascular conditions, cancer, chronic respiratory disease, and diabetes, remain the leading cause of mortality, accounting for approximately 80% of all deaths, driving expanded demand for long‑term care and specialist services.

As of the end‑of 2024, Vietnam’s hospital network comprised over 1,700 facilities, with bed availability estimated at 34 beds per 10,000 people, meeting or exceeding national targets and reflecting decades of capacity growth. High demand is evidenced by widespread outpatient care, with millions of visits recorded annually, particularly in institutional settings such as district and central hospitals.

Disease trends show a rising clinical burden of metabolic dysfunction‑associated with fatty liver disease (MAFLD), affecting over 20% of adults in urban populations, closely tied with diabetes and obesity, and increasing utilization of tertiary care resources. Concurrently, dengue incidence in 2025 surged to over 181,000 reported cases with associated mortality, highlighting persistent infectious disease pressures alongside NCDs. These dual disease burdens are shaping patient demand patterns across institutional and community health services, influencing capacity planning and resource allocation across the sector.

The Vietnamese government has pursued expanded health insurance coverage through social health insurance reforms, achieving high coverage rates among citizens and facilitating increased utilization of health services. Strategic investments in digital health, electronic health records, and telemedicine aim to improve patient flow, reduce hospital overcrowding, and enhance access for rural and marginalized populations.

In summary, Vietnam’s healthcare market is expanding within a framework of regulatory reform, demographic change, and disease transition, supported by government policy, infrastructure enhancement, and technology adoption. These developments are expected to sustain healthcare demand growth through 2032 as capacity, digital integration, and preventive care frameworks continue to evolve.

Vietnam Healthcare Market Scope:

 Category  Segments
By Healthcare Expenditure Type (Public Healthcare Expenditure, Private Healthcare Expenditure, Out-of-Pocket Expenditure),
By Pharmaceutical Segment (Prescription Drugs, Over-the-Counter (OTC) Drugs, Generic Drugs, Branded Drugs, Biologics & Biosimilars),
By Therapeutic Area (Cardiovascular Diseases, Oncology, Diabetes, Respiratory Diseases, Neurology, Infectious Diseases, Others),
By Medical Device Type (Diagnostic Imaging Devices, Patient Monitoring Devices, Surgical Equipment, In-vitro Diagnostics, Orthopedic Devices, Cardiovascular Devices, Others),
By Technology Type (Artificial Intelligence in Healthcare, Telemedicine & Remote Monitoring, Electronic Health Records (EHR), Healthcare Analytics, Robotic Surgery, Wearables & Health Apps),
By Healthcare Workforce (Physicians, Nurses, Dentists, Allied Health Professionals),
By Insurance Type (Public Health Insurance, Private Health Insurance),
By Disease Category (Chronic Diseases, Infectious Diseases, Mental Health Disorders),
By End User (Hospitals, Clinics, Diagnostic Centers / Laboratories, Ambulatory Surgical Centers, Home Healthcare, Research Institutes, Pharmacies, Others)

Vietnam Healthcare Market Driver:

Rising Prevalence of Non-Communicable Diseases

The rising prevalence of noncommunicable diseases (NCDs) in Vietnam is the foremost structural driver expanding the healthcare market. Urbanization, dietary changes, and lifestyle-related risk factors have intensified incidence rates, stimulating consistent demand for diagnostics, hospital care, and specialized treatment services.

NCDs structurally increase healthcare utilization across institutional and community segments. Patients with chronic illnesses require frequent outpatient consultations, long-term medication, laboratory monitoring, and hospitalization for acute episodes, creating sustained service volumes. The Ministry of Health reports that earlier estimates indicated that approximately 15 million individuals in Vietnam were living with hypertension and diabetes ; however, it is important to note that this figure reflects the prevalence of these conditions rather than actual annual hospital visits or healthcare service utilization. This multi-level requirement ensures that NCD-driven demand affects nearly all segments of the healthcare system rather than a single service line.

Government initiatives amplify this driver by integrating NCD management into national policy frameworks. Vietnam’s newly adopted Law on Disease Prevention includes provisions that require organizing early detection, counseling, monitoring, and preventive treatment for persons at risk of noncommunicable diseases in the community, showing official emphasis on systematic prevention and early management. This demonstrates government policy directly targeting structural NCD control. Coverage ensures financial access to chronic care, enabling regular monitoring and adherence to long-term treatment plans. This structural alignment of disease prevalence, policy support, and financial coverage creates a durable expansion of healthcare service volume, reinforcing NCDs as a systemic and high-impact driver of Vietnam’s healthcare market growth.

  1. Introduction
  2. Executive Summary
    1. Key Insights
    2. Key Findings (2020–2024)
    3. Market Outlook Snapshot (2025–2032F)
    4. Strategic Imperatives
  3. Macro Environment Analysis
    1. Vietnam at a Glance
      1. Geographic Overview
      2. Political Structure
      3. Trade & Regional Alliances
      4. Others
    2. Demographic Profile (2020–2032F)
      1. Population Trends
      2. Age Structure
      3. Urban vs Rural Distribution
      4. Fertility Rate Trends
      5. Migration Trends
      6. Ethnic Composition
    3. Economic Profile (2020–2032F)
      1. GDP (Current & Constant USD)
      2. GDP by Sector
      3. Working Population & Labor Participation
      4. Per Capita Income & Purchasing Power
      5. Unemployment & Underemployment
      6. Inflation Rate & Healthcare Cost Impact
      7. Foreign Direct Investment Trends
    4. Country PESTLE Analysis
  4. Vietnam Healthcare Market Analysis, 2026
    1. Healthcare System Overview
      1. Structure of Healthcare System
      2. Public vs Private Healthcare
      3. Governance & Regulatory Authorities
      4. Others
    2. Healthcare Ecosystem & Infrastructure (2020–2026)
      1. Healthcare Expenditure
        1. Healthcare Expenditure as % of GDP
        2. Per Capita Healthcare Expenditure
      2. Healthcare Facilities
        1. Number of Hospitals
        2. Number of Clinics
        3. Number of Pharmacies
        4. Number of Diagnostic Centres
        5. Public vs Private Distribution
        6. Bed Availability & Utilization
          1. Beds per 1,000 Population
          2. Beds Speciality
          3. Regional Disparities
      3. Healthcare Workforce
        1. Physicians per 1,000 Population
        2. Physicians by Speciality
        3. Nurses
        4. Dentists
        5. Allied Health Professionals
  5. Health Outcomes & Public Health Indicators (2020–2026)
    1. Life Expectancy (Male vs Female)
    2. Infant Mortality Rate
    3. Maternal Mortality Ratio
    4. Immunisation Coverage Rates (Measles, DPT, HPV, COVID-19)
    5.  Overall Disease Burden Trends
  6. Healthcare Reforms & Large-Scale Projects (2020-2026)
    1. Government Reforms
    2. Public-Private Partnerships
    3. Infrastructure Expansion Projects
    4. Private Sector Investments
    5. Others
  7. Insurance Framework
    1. Public Health Insurance Programs
    2. Private Health Insurance Market
    3. Insurance Penetration & Coverage Gaps
    4. Payer Landscape
    5. Reimbursement Models (FFS, Bundled, Value-Based Care)
    6. Claims Management & Transparency Issues
    7. Out-of-Pocket Expenditure Trends (2020-2026)
  8. Regulatory Environment (Healthcare Sector)
    1. Market Authorisation for Pharmaceuticals
    2. Market Authorisation for Medical Devices
    3. Licensing for Manufacturing, Import & Export
    4. Clinical Trial Regulations
    5. Intellectual Property & Patent Protection
    6. Advertising, Labeling & Packaging Regulations
    7. Pharmacy & Hospital Licensing Rules
    8. Others
  9. Market Dynamics & Technology
    1. Healthcare Market Dynamics
      1. Growth Drivers
      2. Challenges & Barriers
      3. Emerging Opportunities
      4. Value Chain Analysis
    2. Healthcare Technology Trends
      1. Digital Health Maturity
      2. Telemedicine & Remote Monitoring
      3. Artificial Intelligence & Machine Learning
      4. Health Apps & Wearables
      5. Robotic Surgery
      6. EHR, Data Interoperability & Cybersecurity
      7. Others
  10. Epidemiology Profile (By Age & By Gender) (2020–2032F)
    1. Chronic Diseases
      1. Cardiovascular Diseases
        1. Prevalence
        2. Incidence
        3. Mortality Rate
        4. Risk Factors
        5. Healthcare & Economic Burden
        6. Infrastructure Challenges
        7. Treatment Landscape
        8. Others
      2. Diabetes
        1. Prevalence
        2. Incidence
        3. Mortality Rate
        4. Risk Factors
        5. Healthcare & Economic Burden
        6. Infrastructure Challenges
        7. Treatment Landscape
        8. Others
      3. Cancer
        1. Prevalence
        2. Incidence
        3. Mortality Rate
        4. Risk Factors
        5. Healthcare & Economic Burden
        6. Infrastructure Challenges
        7. Treatment Landscape
        8. Others
      4. Chronic Respiratory Diseases
        1. Prevalence
        2. Incidence
        3. Mortality Rate
        4. Risk Factors
        5. Healthcare & Economic Burden
        6. Infrastructure Challenges
        7. Treatment Landscape
        8. Others
      5. Chronic Kidney Disease
        1. Prevalence
        2. Incidence
        3. Mortality Rate
        4. Risk Factors
        5. Healthcare & Economic Burden
        6. Infrastructure Challenges
        7. Treatment Landscape
        8. Others
    2. Infectious Diseases
      1. Tuberculosis
        1. Prevalence
        2. Incidence
        3. Mortality Rate
        4. Risk Factors
        5. Healthcare & Economic Burden
        6. Infrastructure Challenges
        7. Treatment Landscape
        8. Others
      2. HIV
        1. Prevalence
        2. Incidence
        3. Mortality Rate
        4. Risk Factors
        5. Healthcare & Economic Burden
        6. Infrastructure Challenges
        7. Treatment Landscape
        8. Others
      3. Hepatitis
        1. Prevalence
        2. Incidence
        3. Mortality Rate
        4. Risk Factors
        5. Healthcare & Economic Burden
        6. Infrastructure Challenges
        7. Treatment Landscape
        8. Others
      4. Others
    3. Mental Health
      1. Prevalence of Mental Health Disorders
      2. Suicide Rates & Trends
      3. Urban-Rural & Gender Disparities
      4. Infrastructure Gaps
      5. Economic & Social Burden
  11. Vietnam Healthcare Market Stakeholders Analysis, 2026
    1. Vietnam Pharmaceutical Market Outlook (2020–2030F)
      1. Market Size & Growth
        1. Market Size (USD Million), 2020-2030F
        2. Market by Key Segments
          1. Prescription vs OTC
          2. Generics vs Branded
          3. Therapeutic Category Distribution
      2. Manufacturing Landscape
      3. Distribution & Supply Chain
        1. Major Distributors
        2. Major Suppliers
      4. Major Local and Multinational Players
      5. Pharmaceutical sector (Top 5–10 companies, % market share)
      6. Imports & Exports (Value in USD Million) (2020-2026)
      7. Key Pharmaceutical Clusters (if there)
      8. Investments and R&D (2020-2026)
      9. Others
    2. Vietnam Medical Devices Market Outlook (2020–2030F)
      1. Market Size & Growth
        1. Market Size (USD Million), 2020-2030F
        2. Market by Key Segments
          1. By Device Type
          2. By Risk Class
          3. By End-User
      2. Manufacturing Landscape
      3. Distribution & Supply Chain
        1. Distributors
        2. Supply Chain
      4. Major Local and Multinational Players
      5. Medical Devices Sector (Top 5–10 companies, % market share)
      6. Imports & Exports (Value in USD Million) (2020-2026)
      7. Key Medical Device Clusters (if there)
      8. Investments and R&D (2020-2026)
      9. Others
  12. Vietnam Strategic & Investments in Healthcare Outlook (2025-2032F)
    1. High-Growth Segments
    2. Foreign Investment Opportunities
    3. Government Incentives & Ease of Doing Business
    4. Risk Assessment & Mitigation
  13. Trade Associations & Industry Bodies
    1. Pharmaceutical Associations
    2. Medical Device Associations
    3. Healthcare Provider Associations
    4. Regulatory & Standards Bodies
  14. Healthcare Trade Fairs & Conferences (2024–2026)
    1. National Healthcare Exhibitions
    2. Medical Technology Events
    3. Pharmaceutical Conferences
    4. Regional Latin America Events Relevant to Vietnam
  15. Impact of Global Health Events
    1. COVID-19 Impact (2020–2022)
    2. Post-Pandemic Recovery
    3. Emergency Preparedness Evolution
  16. Strategic Recommendations
    1. Market Entry Strategy
    2. Partnership Models
    3. Pricing Strategy
    4. Regulatory Navigation
  17. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now
Inquire Before Buying
Customization Offered
  • Cross-segment Market Size & Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics & Share
  • Import Export & Production Analysis
Request Customization
Related Reports